Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Zoll Medical, a manufacturer of resuscitation devices and related software solutions, and Masimo, a manufacturer of noninvasive patient monitoring technologies, have jointly announced a multi-year technology agreement to integrate Rainbow Set technology into Zoll E Series defibrillators.
Subscribe to our email newsletter
The agreement reportedly allows Zoll to manufacture the Zoll E Series defibrillators with the Rainbow Set technology that non-invasively and continuously measures carbon monoxide and methemoglobin levels in the blood.
According to Zoll Medical, Masimo Rainbow Set Pulse CO-Oximetry is the first-and-only technology platform capable of noninvasively and continuously measuring total hemoglobin, oxygen content, carboxyhemoglobin, methemoglobin, and pleth variability index, in addition to oxyhemoglobin, perfusion index and pulse rate.
Masimo Rainbow Set – featuring the accuracy and reliability of Masimo Set measure – through motion and low perfusion pulse oximetry, significantly expands traditional noninvasive patient monitoring capabilities to quickly and easily measure, track and monitor blood constituents that previously required invasive procedures.
Richard Packer, chairman and CEO of Zoll, said: “Masimo Rainbow Set Pulse CO-Oximetry non-invasively delivers the advanced clinical intelligence that emergency medical service and fire professionals need to accurately diagnose and treat victims of carbon monoxide poisoning. This agreement will allow us to add this important parameter in the future to help rescuers advance their lifesaving efforts.”